ROSHAN KURIEN: Open Payments
NPI 1770226821 · WEST ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,756 in 192 payments from 23 companies in 2025. Trend: 2023 $707 · 2024 $3,563 · 2025 $3,756
Food & beverage: $3,756
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 28 | $552 |
| ABBVIE INC. | 16 | $367 |
| Janssen Pharmaceuticals, Inc | 9 | $302 |
| Alkermes, Inc. | 14 | $244 |
| Corium, LLC | 14 | $241 |
| Otsuka America Pharmaceutical, Inc. | 12 | $232 |
| Supernus Pharmaceuticals, Inc. | 17 | $225 |
| E.R. Squibb & Sons, L.L.C. | 10 | $209 |
| Teva Pharmaceuticals USA, Inc. | 13 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $177 |
Products named: REXULTI, VRAYLAR, SPRAVATO, Azstarys, Qelbree, COBENFY, ARISTADA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
